Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which wouldconstitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Tropical Medicine Research Centers.
Date: October 16-18, 2006.
Time: 8 a.m. to 12 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Gary S. Madonna, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/Start Printed Page 56994NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, (301) 496-3528. firstname.lastname@example.org.
Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Malaria Vaccine Production and Support Services.
Date: October 20, 2006.
Time: 2 p.m. to 5:30 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Room 3147, Bethesda, MD 20817 (Telephone Conference Call).
Contact Person: Mary J. Homer, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, (301) 496-7042. email@example.com.Start Signature
(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)
Dated: September 19, 2006.
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-8330 Filed 9-27-06; 8:45 am]
BILLING CODE 4140-01-M